Literature DB >> 11129008

Evaluating the effects of oral prednisolone on recovery after tonsillectomy: a prospective, double-blind, randomized trial.

C E Palme1, P Tomasevic, D V Pohl.   

Abstract

OBJECTIVES: To investigate the role of a 7-day course of oral prednisolone on recovery from tonsillectomy. STUDY
DESIGN: Double-blind, randomized, placebo-controlled trial of 50 consecutive patients, aged 5 years and older, who had no previous or known contraindications to steroid therapy.
METHODS: The patients were randomized at the time of surgery to either a 7-day course of daily placebo or prednisolone (dosage: 10 mg per day in patients aged 5-11 y, 0.5 mg/kg in those aged 12 and older). Age, sex, weight, diagnosis, tonsil size (in cm2), additional adenoidectomy, performing surgeon, method of dissection, length of procedure, total blood loss, intraoperative fluid requirement, and length of hospitalization were documented for each patient. During the first postoperative day, morning pain score, paracetamol use, oral fluid intake, temperature, presence of nausea and vomiting, level of activity (low, moderate, or normal), and type of diet (liquid, soft, or normal) were recorded.
RESULTS: The steroid group consisted of a greater number of diathermy dissection cases and had significantly less intraoperative blood loss (P value = .022 and .017, respectively). On postoperative days 4 to 7, the steroid group experienced less nausea and vomiting (P value = .01, .04, .04, and .04, respectively). Paracetamol use was less in the steroid group on days 2, 7, and 8 (P value = .03, .02, and .02, respectively). There was no difference between the two groups for the other data measured.
CONCLUSION: A 7-day course of corticosteroids may play a limited role in patients' recovery from tonsillectomy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129008     DOI: 10.1097/00005537-200012000-00003

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

Review 1.  Steroids for improving recovery following tonsillectomy in children.

Authors:  David L Steward; Jedidiah Grisel; Jareen Meinzen-Derr
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

2.  Treatment of primary snoring using modified radiofrequency-assisted uvulopalatoplasty.

Authors:  Ozgur Yoruk; Metin Akgun; Yavuz Sutbeyaz; Bulent Aktan; Harun Ucuncu; Arzu Tatar; Enver Altas; Omer Araz; Ali Fuat Erdem
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-02-26       Impact factor: 2.503

3.  The effects of dexamethasone and levobupivacaine on postoperative pain in modified radiofrequency assisted uvulopalatoplasty (MRAUP) surgery.

Authors:  Arzu Onder Tatar; Ozgur Yoruk; Metin Akgun
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-10       Impact factor: 2.503

Review 4.  [Steroids for reduction of morbidity following tonsillectomy].

Authors:  J P Windfuhr
Journal:  HNO       Date:  2008-01       Impact factor: 1.284

5.  Effect of systemic steroids on post-tonsillectomy bleeding and reinterventions: systematic review and meta-analysis of randomised controlled trials.

Authors:  Jennifer Plante; Alexis F Turgeon; Ryan Zarychanski; François Lauzier; Louise Vigneault; Lynne Moore; Amélie Boutin; Dean A Fergusson
Journal:  BMJ       Date:  2012-08-28

6.  Steroid therapy for post-tonsillectomy symptoms in adults: a randomized, placebo-controlled study.

Authors:  Ali Maeed Al-Shehri
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

7.  The effect of dexamethasone on post-tonsillectomy nausea, vomiting and bleeding.

Authors:  Jochen P Windfuhr; Yue-Shih Chen; Evan J Propst; Christian Güldner
Journal:  Braz J Otorhinolaryngol       Date:  2011-06

8.  Antibiotic use in post-adenotonsillectomy morbidity: a randomized prospective study.

Authors:  Marja Michelin Guerra; Eduardo Garcia; Renata Ribeiro de Mendonça Pilan; Priscila Bogar Rapoport; Caio Barbosa Campanholo; Eli Onivaldo Martinelli
Journal:  Braz J Otorhinolaryngol       Date:  2008 May-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.